Cleared Traditional

K061855 - NEUROQUANT

K061855 is an FDA 510(k) clearance for NEUROQUANT, manufactured by Cortechs Labs, Inc.. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 41-day FDA review.

K061855 · Cortechs Labs, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2006
Decision
41d
Days
Class 2
Risk

K061855 is an FDA 510(k) clearance for the NEUROQUANT. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Cortechs Labs, Inc. (La Jolla, US). The FDA issued a Cleared decision on August 10, 2006 after a review of 41 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Cortechs Labs, Inc. devices

FDA 510(k) Submission Details - K061855

510(k) Number K061855 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 30, 2006
Decision Date August 10, 2006
Days to Decision 41 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
66d faster than avg
Panel avg: 107d · This submission: 41d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1193
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K061855.
XCELERA
K061995 · Philips Medical Systems North America Co. · Sep 2006
VITREAACCESS, VERSION 1.0
K062328 · Vital Images, Inc. · Aug 2006
SECURVIEW DX DIAGNOSTIC WORKSTATION, MODELS SV-0001, SV-0002 AND SV-0003
K062107 · Hologic, Inc. · Aug 2006
VITAL CONNECT 4.0
K062154 · Vital Images, Inc. · Aug 2006
MONOCHROME LCD MONITOR, RADIFORCE, GS320
K062053 · Eizo Nanao Corporation · Aug 2006
SYNGO MULTIMODALITY WORKPLACE
K061964 · Siemens AG Medical Solutions · Jul 2006